• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; INSERT, TUBAL OCCLUSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; INSERT, TUBAL OCCLUSION Back to Search Results
Model Number ESS305
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cyst(s) (1800); Gastritis (1874); Headache (1880); Hypersensitivity/Allergic reaction (1907); Pain (1994); Tinnitus (2103); No Code Available (3191)
Event Type  Injury  
Event Description
This spontaneous case was reported by a consumer and describes the occurrence of pelvic pain ("pelvic pain") and ovarian cyst ("suspect ovarian cyst that developed very quickly") in a female patient who had essure inserted for female sterilization.The occurrence of additional non-serious events is detailed below.The patient's past medical history included allergy to metals.I had always been in good health.On an unknown date, the patient had essure inserted.On an unknown date, the patient experienced pelvic pain (seriousness criteria medically significant and intervention required), ovarian cyst (seriousness criterion medically significant), migraine ("migraines"), neuralgia ("nerve pain"), headache ("headaches"), hyperacusis ("painful and highly incapacitating hyperacusis"), tinnitus ("tinnitus"), allergy to metals ("allergy to nickel, cobalt and chrome"), gastric disorder ("stomach problems with new food intolerances") and food intolerance ("stomach problems with new food intolerance").The patient was treated with surgery (essure removal, total hysterectomy) and surgery (total hysterectomy).Essure was removed.At the time of the report, the pelvic pain, ovarian cyst, migraine, neuralgia, headache, hyperacusis, tinnitus and allergy to metals outcome was unknown and the gastric disorder and food intolerance had resolved.The reporter considered allergy to metals, food intolerance, gastric disorder, headache, hyperacusis, migraine, neuralgia, ovarian cyst, pelvic pain and tinnitus to be related to essure.The reporter commented: an article on a blog.The suspect ovarian cyst developed very quickly and required total hysterectomy.It was my gp who sounded the alarm as concerns the inserts and my allergic background and who had tested me against nickel, chrome, cobalt, which came back positive.The gynaecologist, who knew about my allergic diathesis, did not see any problem with placing the inserts.Just a few days after removal, my stomach problems were over.I was able to start eating milk products again, gluten and all the vegetables excluded from my diet, much to my surprise.That's when i had the proof i needed.I had always been in good health, i had no choice with that cyst.I am recovering little by little, and hope the other symptoms will resolve.Diagnostic results (normal ranges are provided in parenthesis if available): allergy test - on an unknown date: positive against nickel, chrome, cobalt (abnormal nos).The list of device similar incidents contains essure reports received by bayer and older cases received by conceptus coded with the same meddra preferred term.In this particular case a search in the database was performed on (b)(6) 2017 for the following meddra preferred term: pelvic pain: the analysis in the global safety database revealed 3083 cases.Bayer is closely monitoring the benefit-risk profile of essure.A recent cumulative review of all available data on essure has not yielded any new safety signal with regard to this meddra pt.Further company follow-up with the consumer is not possible.Incident: no lot number or sample available for investigation.There is no evidence that a device-related defect or malfunction caused a death or serious injury.If additional information becomes available, it will be provided on a supplemental report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
INSERT, TUBAL OCCLUSION
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM   13353
Manufacturer Contact
k shaw lamberson
100 bayer blvd.
p.o. box 915
whippany, NJ 07981-0915
MDR Report Key6727515
MDR Text Key80538013
Report Number2951250-2017-02578
Device Sequence Number1
Product Code HHS
Combination Product (y/n)N
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other
Type of Report Initial
Report Date 07/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberESS305
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/10/2017
Initial Date FDA Received07/20/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-